Hussman Strategic Advisors Q4 2025 13F Holdings and Activity Report

I. Institutional Overview

The psychological portrait of Hussman Strategic Advisors is one of extreme discipline and risk-aversion, often manifesting in a "contrarian-value" stance. Hussman is famously cautious during periods of market exuberance, frequently citing historical valuation extremes as a reason for defensive positioning. However, the 13F report—which only captures long equity positions—presents a fascinating look at the "selection" side of his strategy. With 252 holdings , the portfolio is characterized by a high degree of diversification. This is not a "high-conviction, few-bets" shop in the traditional sense; rather, it appears to be a systematic implementation of value factors across a broad spectrum of equities. The average position size is relatively small, with the largest holding, QCOM (QUALCOMM Incorporated) , representing only 1.13% of the total portfolio. This suggests a "quant-mental" approach where the manager identifies a specific set of fundamental characteristics—likely involving cash flow yield, valuation multiples, and perhaps technical trend filters—and applies them across hundreds of stocks to mitigate idiosyncratic risk.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

II. Sector Allocation Analysis

The outsized allocation to Healthcare is the most striking feature of the Q4 2025 report. In a macro environment characterized by uncertainty regarding interest rates and global growth, Healthcare serves as a "safe harbor." However, looking at the underlying holdings like ACAD (ACADIA Pharmaceuticals) and HALO (Halozyme Therapeutics) , it is clear that Hussman is not just buying "Big Pharma" like Pfizer or Merck. He is venturing into mid-cap biotech and specialized medical services. This suggests a belief that the healthcare sector offers idiosyncratic growth opportunities that are decoupled from the broader market's valuation extremes. The logic here is likely twofold: (1) aging demographics provide a structural tailwind, and (2) many biotech names were severely de-rated in previous years, offering the "valuation trough" that Hussman’s contrarian soul craves.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

III. Top 10 Holdings Deep Dive

Qualcomm’s ascent to the #1 spot as a New Buy is a significant statement. In the hierarchy of semiconductor companies, Qualcomm is often viewed as a "value" play compared to the astronomical valuations of Nvidia or AMD. By making QCOM his largest position, Hussman is expressing a "Conviction Holding" in the edge-AI and 5G recovery story.

The Top 10 holdings reveal a portfolio that is valuation-sensitive but growth-aware . Hussman is not buying "cigar butts" (dying companies at cheap prices); he is buying high-quality businesses (QCOM, UI, CHKP) when the market offers a discount. The sector distribution is heavily tilted toward Tech and Healthcare, but the "style" is consistently "Large/Mid-Cap Value." This construction provides a lower beta than the S&P 500 while maintaining exposure to the most productive parts of the economy.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

IV. Major Buys/Additions

The major buys are clustered in Technology (QCOM, CHKP, CSIQ) , Healthcare (CVS, NUTX) , and Consumer Staples (TR, KO) . This reveals a clear strategy: Hussman is rotating capital into "Essential Services" and "Productive Technology." The trend here is a move away from "Software-as-a-Service" (SaaS)—which he exited heavily (see Section V)—and toward "Hardware, Infrastructure, and Physical Goods." This is a "Back to Basics" approach that favors companies with tangible assets and proven profitability.

The total estimated addition amount from the top 10 buys is approximately $33 million . When compared to the cash recouped from the 120 exits (which include names like Meta and Lululemon), it is clear that Hussman is performing a "Strategic Reallocation." He is not necessarily adding "new" money to the market; rather, he is "cleaning the house." He is selling the "expensive winners" of the past decade and buying the "ignored value" of the next. This rotation from "Growth" to "Value" is the defining theme of the quarter.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

V. Major Sells and Exits

The overall quality of these exits is high. Hussman is not just "panic selling"; he is systematically removing stocks that no longer fit his "Value/Contrarian" criteria. The exit from MTB (M&T Bank) suggests a cautious view on the regional banking sector, while the exit from UPS (United Parcel Service) indicates concerns about global logistics and consumer demand. By clearing out 120 names, Hussman has "de-cluttered" the portfolio, focusing his capital on a fresher set of ideas.

The primary risk signal from these exits is "Valuation Exhaustion." Hussman is warning that the stocks that led the market for the last five years may not be the ones that lead for the next five. His exit from EPAM Systems and Globant specifically points to a risk in "Human-Capital-Intensive Tech Services," which may be the first casualty of the AI era.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

VI. Investment Insights and Risk Warnings

Hussman’s actions this quarter reveal a profound skepticism toward the "growth at any price" narrative that has dominated the US equity markets. His logic chain is clear: 1. Sold What : He exited 120 positions, primarily high-multiple growth stocks (Lululemon, Globant), SaaS companies (Twilio, DocuSign), and crowded mega-cap tech (Meta). 2. Why Sell : These names either reached valuation extremes, suffered fundamental breakdowns (de-rating), or became "consensus trades" that offer little contrarian upside. 3. Bought What : He initiated major positions in "Value Tech" (Qualcomm, Check Point), "Essential Services" (CVS, Verizon), and "Defensive Staples" (Coca-Cola, Tootsie Roll). 4. Why Buy : These companies offer "Tangible Value"—real earnings, strong cash flows, and reasonable valuations. They are the "ballast" that can withstand a stagflationary or low-growth macro environment. 5. Overall Result : The portfolio has been "scrubbed" of speculative excess and repositioned into a "Barbell" of defensive safety and contrarian value.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

Sources and limitations

This report uses public U.S. Securities and Exchange Commission Form 13F disclosures and structured data maintained by 13F Hub. A 13F filing is a quarter-end snapshot of reportable long positions, is normally published with a delay, and does not disclose every short position, cash balance, bond, derivative, or non-U.S. asset.

Narrative content is prepared from the same-period SEC disclosure and 13F Hub structured data, then checked before publication. This material is for research and education, not personalized investment advice.